Clinical impact of the 2010–2012 low-end shift of high-sensitivity cardiac troponin T

Abstract

Background:

The clinical implications of the 2010–2012 low-end shift of high-sensitivity cardiac troponin T (hs-cTnT) regarding possible misdiagnosis of acute myocardial infarction are largely unknown.

Methods:

We aimed to quantify the impact of the 2010–2012 low-end shift and adjustment issue in 857 patients presenting to the emergency department with suspected acute myocardial infarction by comparing measurements performed with affected 2010–2012 lots with recalculated 2010–2012 values using a linear regression formula (provided by the manufacturer) and the corrected assay (re-measured in 2013). The final diagnosis was adjudicated by two independent cardiologists using all information including coronary angiography, echocardiography and serial hs-cTnT levels (with the corrected 2013 assay).

Results:

Acute myocardial infarction was the adjudicated diagnosis in 195 patients (22.7%). Median hs-TnT values were 8.5 ng/l for affected lots, 11.1 ng/l with recalculated and 10 ng/l with the corrected assay (P<0.001 for all comparisons). Spearman correlation coefficient was 0.937 (<0.001) for correct and affected respective correct and recalculated values. The Cusum test indicated significant deviation from linearity (P<0.01) for both correlations. Deviations nearly exclusively affected hs-cTnT levels below the 99th percentile (14 ng/L). Among the 195 patients with an adjudicated diagnosis of acute myocardial infarction, no patient was misclassified using affected lots if using conventional serial sampling. In contrast, misdiagnosis of acute myocardial infarction was significantly increased by affected lots if applying the novel ESC 0 h/1 h algorithm for the early rule-out of acute myocardial infarction (negative predictive value with affected lots 97.7% versus 99.7% with corrected lots).

Conclusion:

The 2010–2012 hs-cTnT low-end shift affected nearly exclusively levels below the 99th percentile cut-off. While it did not affect the diagnosis of acute myocardial infarction when using conventional serial sampling as done in 2010–2012, it would impact on new early rule-out strategies using very low levels of hs-cTnT such as the ESC 0 h/1 h algorithm.

Clinical Trials registration:

NCT0047058, NCT00470587

Keywords

High-sensitivity cardiac troponin T (hs-cTnT)diagnosis of acute myocardial infarction low-end shift of hs-cTnT recalculation of hs-cTnT clinical implication

Get full access to this article

View all access options for this article.

References

Hamm

Bassand

J-P

Agewall

. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting Without Persistent ST-elevation. Eur Heart J 2011; 32: 2999–3054.

Thygesen

Alpert

White

. Universal definition of myocardial infarction. Circulation 2007; 116: 2634–2653.

Thygesen

Mair

Katus

. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 2010; 31: 2197–2204.

Twerenbold

Jaffe

Reichlin

. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012; 33: 579–586.

Giannitsis

Kurz

Hallermayer

. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56: 254–261.

Kavsak

MacRae

Yerna

. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009; 55: 573–577.

Keller

Zeller

Ojeda

. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011; 306: 2684–2693.

Reichlin

Hochholzer

Bassetti

. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858–867.

Reichlin

Irfan

Twerenbold

. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011; 124: 136–145.

10.

Apple

Jaffe

. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin Chem 2012; 58: 1599–1600.

11.

Hallermayer

Jarausch

Menassanch-Volker

. Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin Chem 2013; 59: 572–574.

12.

Kavsak

Hill

McQueen

. Implications of adjustment of high-sensitivity cardiac troponin T assay. Clin Chem 2013; 59: 574–576.

13.

Kuster

Dupuy

A-M

Monnier

. Letters to the Editor: Implications of adjustment of high-sensitivity cardiac troponin assay. Clin Chem 2012; 59: 570–571.

14.

Reiter

Twerenbold

Reichlin

. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 2011; 33: 988–997.

15.

Haaf

Drexler

Reichlin

. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012; 126: 31–40.

16.

Thygesen

Alpert

Jaffe

. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551–2567.

17.

Thygesen

Mair

Giannitsis

. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012; 33: 2252–2257.

18.

Mueller

Biener

Vafaie

. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012; 58: 209–218.

19.

Vasile

Saenger

Kroning

. Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56: 1086–1090.

20.

Todd

. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009; 55: 52–58.

21.

Keller

Zeller

Peetz

. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361: 868–877.

22.

Reichlin

Schindler

Drexler

. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012; 172: 1211.

23.

Hoeller

Rubini Giménez

Reichlin

. Normal presenting levels of high-sensitivity troponin and myocardial infarction. Heart 2013; 99(21): 1567–1572.

24.

Rubini Giménez

Hoeller

Reichlin

. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013; 168: 3896–3901.

25.

Body

Carley

McDowell

. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011; 58: 1332–1339.

26.

Bandstein

Ljung

Johansson

. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014; 63: 2569–2578.

27.

Zhelev

Hyde

Youngman

. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis. BMJ 2015; 350: h15.

28.

Roffi

Patrono

Collet

J-P

. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2015; ehv320.

29.

Rubini Gimenez

Twerenbold

Jaeger

. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. hs-Cardiac troponin T for 1-hour diagnosis of AMI. Am J Med 2015; 128(8): 861–870.

30.

Jaeger

Wildi

Twerenbold

. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am Heart J 2016; 171: 92–102.e5.

31.

de Lemos

Drazner

Omland

. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304: 2503–2512.

32.

Reichlin

Irfan

Twerenbold

. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011; 124: 136–145.

33.

Haaf

Drexler

Reichlin

. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012; 126: 31–40.

34.

Artunc

Mueller

Breidthardt

. Sensitive troponins – which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One 2012; 7: e47610.

35.

McMurray

Adamopoulos

Anker

. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787–1847.

36.

Konstantinides

Torbicki

Agnelli

. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014; 35: 3033–3069.